Part 9: Acute Coronary Syndromes: 2015 Guidelines Update Writing Group Disclosures
Writing Group Member Employment Research Grant Other Research Support Speakers’ Bureau/Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other
Robert E. O’Connor University of Virginia None None None None None None None
Abdulaziz S. Al Ali McMaster University None None None None None None None
William J. Brady University of Virginia Siemens Medical Diagnostics* None None Medicolegal consulting* None EvidenceCare† None
Chris A. Ghaemmaghami University of Virginia None None None None None None None
Venu Menon Cleveland Clinic Astra Zeneca* None None None None Astra Zeneca*; Takeda
Pharmaceuticals†
None
Michelle Welsford Centre for Paramedic Education and Research None None None None None None None
Consultant
Michael Shuster Mineral Springs Hospital None None None None None American Heart Association† None
This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.

†Significant.